Free Trial
NASDAQ:YS

YS Biopharma (YS) Stock Price, News & Analysis

$0.92
-0.06 (-6.13%)
(As of 05/22/2024 ET)
Today's Range
$0.88
$0.98
50-Day Range
$0.63
$1.03
52-Week Range
$0.35
$1.78
Volume
37,682 shs
Average Volume
79,025 shs
Market Capitalization
$85.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.25

YS Biopharma MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
471.3% Upside
$5.25 Price Target
Short Interest
Healthy
0.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of YS Biopharma in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.45) to ($0.25) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.57 out of 5 stars

Medical Sector

449th out of 919 stocks

Pharmaceutical Preparations Industry

192nd out of 413 stocks

YS stock logo

About YS Biopharma Stock (NASDAQ:YS)

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

YS Stock Price History

YS Stock News Headlines

See More Headlines
Receive YS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/23/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Fax
N/A
Employees
773
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.25
High Stock Price Target
$5.25
Low Stock Price Target
$5.25
Potential Upside/Downside
+471.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100 million
Book Value
$1.14 per share

Miscellaneous

Free Float
N/A
Market Cap
$85.51 million
Optionable
Not Optionable
Beta
0.51
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Gang Li (Age 42)
    Head of Marketing & Sales
  • Dr. Yuan Liu Ph.D. (Age 37)
    Head of Vaccine Research
  • Dr. Hui Shao C.F.A. (Age 56)
    M.B.A., Ph.D., President, CEO & Executive Director
  • Dr. Zenaida Reynoso Mojares M.D. (Age 65)
    Chief Medical Officer

YS Stock Analysis - Frequently Asked Questions

Should I buy or sell YS Biopharma stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for YS Biopharma in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" YS shares.
View YS analyst ratings
or view top-rated stocks.

What is YS Biopharma's stock price target for 2024?

1 Wall Street analysts have issued 12 month price targets for YS Biopharma's stock. Their YS share price targets range from $5.25 to $5.25. On average, they anticipate the company's share price to reach $5.25 in the next twelve months. This suggests a possible upside of 471.3% from the stock's current price.
View analysts price targets for YS
or view top-rated stocks among Wall Street analysts.

How have YS shares performed in 2024?

YS Biopharma's stock was trading at $0.5110 at the beginning of 2024. Since then, YS shares have increased by 79.8% and is now trading at $0.9189.
View the best growth stocks for 2024 here
.

How do I buy shares of YS Biopharma?

Shares of YS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:YS) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners